Catapano Joseph Ronald 4

What Happened

• Joseph Ronald Catapano, Chief Accounting Officer of Teladoc Health, had 2,083 restricted stock units (RSUs) convert to 2,083 common shares on July 1, 2026. Those 2,083 shares were surrendered to satisfy tax withholding (no cash proceeds reported). On July 2, 2026 he sold 653 shares in an open-market transaction at $9.10 per share, generating $5,942 in proceeds.
• These actions are primarily a vesting/tax withholding event plus a routine open-market sale (selling is generally considered routine and not necessarily a bullish signal).

Key Details

• Transaction dates and prices:
  • 2026-07-01: 2,083 RSUs converted to 2,083 shares (reported as derivative exercise/conversion, code M); 2,083 shares were disposed to cover tax withholding (no cash).
  • 2026-07-02: 653 shares sold on the open market at $9.10 each for $5,942 total.
• Shares owned after transaction: Not disclosed in the filing.
• Footnotes of note:
  • F1: RSUs convert one-for-one into TDOC common stock.
  • F2: Shares were sold/used to cover tax withholding on RSU vesting.
  • F3: The RSUs relate to a 25,000‑unit grant on Oct 1, 2024 with staged vesting.
• Timeliness: The filing (dated 2026-07-06) reports the July 1 vesting after the two-business-day deadline and thus appears late for that vesting event; the July 2 sale was reported within the required two-business-day window.

Context

• The M-coded transactions reflect exercise/conversion of derivative awards (here, RSU vesting). The immediate disposition of some or all converted shares to cover taxes is a common, non-market-sale method of satisfying withholding obligations (no cash to the insider). The separate July 2 open-market sale generated modest proceeds and is a routine disclosure of insider selling.